M
Maiden Holdings, Ltd.
MHNCCIK 0001412100NYSEAcceleratedSmaller ReportingFire, Marine & Casualty InsuranceD0FY ends Dec 31
Period
FY 2024
Revenue
$56.44M
Net Income
$-200.97M
Total Assets
$1.32B
Equity
$45.19M
Shares Out
99.68M
Op. Cash Flow
$-67.45M
Business
Maiden Holdings, Ltd. is a Bermuda-based holding company that creates shareholder value by owning and managing businesses and assets primarily in the insurance and related financial services industries. It provides reinsurance and insurance services, including run-off reinsurance programs, legacy solutions through its Genesis Legacy Solutions platform, and short-term income protection written by its Scandinavian subsidiaries, with Maiden Global operating as a licensed UK insurance intermediary. Key reportable segments are Diversified Reinsurance and AmTrust Reinsurance. The Company operates principally in Europe and the U.S., distributing through insurer partners, intermediaries and subsidiary channels.
Summary from filing dated 2025-03-10
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 | FY 2020 2020-12-31 |
|---|---|---|---|---|---|---|
| Gross premiums written | 33 | 23 | 5 | 11 | 31 | |
| Net premiums written | 33 | 23 | 5 | 10 | 28 | |
| Change in unearned premiums | 16 | 21 | 33 | 43 | 78 | |
| Net premiums earned | 49 | 44 | 38 | 53 | 106 | |
| Other insurance (expense) revenue, net | −24 | 39,000 | — | — | — | |
| Net investment income | 26 | 37 | 30 | 32 | 55 | |
| Net realized and unrealized investment gains | 6 | 8 | −5 | 13 | 24 | |
| Total revenues | 56 | 89 | 58 | 99 | 184 | |
| Net loss and loss adjustment expenses | 186 | 61 | 58 | 7 | 42 | |
| Commission and other acquisition expenses | 24 | 19 | 19 | 25 | 39 | |
| General and administrative expenses | 35 | 31 | 31 | 36 | 39 | |
| Interest and amortization expenses | 19 | 18 | 19 | — | — | |
| Foreign exchange and other (gains) losses | −7 | 6 | −8 | −8 | 9 | |
| Total expenses | 258 | 135 | 119 | 80 | 148 | |
| Loss before income taxes and interest in income of equity method investments | −202 | −46 | −60 | 19 | 37 | |
| Less: Income tax expense | 1 | 196,000 | −557,000 | 15,000 | −104,000 | |
| Interest in income of equity method investments | 2 | 8 | −205,000 | 8 | 5 | |
| Net loss | −201 | −39 | −60 | 27 | 42 | |
| Basic loss per share attributable to common shareholders (in dollars per share) | −2.01 | −0.38 | 0.63 | 1.35 | 0.93 | |
| Diluted loss per share attributable to common shareholders (in dollars per share) | −2.01 | −0.38 | 0.63 | 1.35 | 0.93 | |
| Weighted average number of common shares - basic (in shares) | 100 | 101 | 87 | 86 | 84 | |
| Weighted average number of common shares - diluted (in shares) | 100 | 101 | 87 | 86 | 84 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 | FY 2020 2020-12-31 |
|---|---|---|---|---|---|---|
| Fixed maturities, available-for-sale, at fair value (Amortized cost: 2024 - $236,788; 2023 - $258,536) | 233 | 251 | 315 | 597 | 1,213 | |
| Equity securities, at fair value (Cost: 2024 - $13,436; 2023 - $39,889) | 13 | 42 | 44 | 24 | — | |
| Equity method investments | 81 | 81 | 80 | 84 | 43 | |
| Other investments (Allowance for expected credit losses: 2024 - $1,023; 2023 - $1,023) | 157 | 186 | 149 | 118 | 64 | |
| Total investments | 484 | 560 | 587 | 823 | 1,320 | |
| Cash and cash equivalents | 26 | 35 | 31 | 27 | 74 | |
| Restricted cash and cash equivalents | 9 | 7 | 16 | 39 | 62 | |
| Accrued investment income | 3 | 5 | 4 | 6 | 11 | |
| Reinsurance balances receivable, net (includes $5,171 and $9,201 from related parties in 2024 and 2023, respectively. Allowance for expected credit losses: 2024 - $169; 2023 - $187) | 8 | 12 | 11 | 20 | 6 | |
| Reinsurance recoverable on unpaid losses (Allowance for expected credit losses: 2024 - $2,963; 2023 - $3,240) | 571 | 564 | 556 | 563 | 593 | |
| Loan to related party | 168 | 168 | 168 | 168 | 168 | |
| Deferred commission and other acquisition expenses (includes $7,553 and $16,605 from related parties in 2024 and 2023, respectively) | 8 | 18 | 25 | 37 | 52 | |
| Funds withheld receivable (includes $0 and $128,451 from related parties in 2024 and 2023, respectively. Allowance for expected credit losses: 2024 - $8; 2023 - $19) | 13 | 144 | 441 | 636 | 655 | |
| Other assets | 5 | 6 | 8 | 5 | 8 | |
| Assets held for sale | 21 | 0 | — | — | — | |
| Total assets | 1,316 | 1,519 | 1,847 | 2,323 | 2,948 | |
| Reserve for loss and loss adjustment expenses (includes $687,274 and $752,991 from related parties in 2024 and 2023, respectively) | 794 | 867 | 1,131 | 1,489 | 1,893 | |
| Unearned premiums (includes $29,204 and $44,577 from related parties in 2024 and 2023, respectively) | 30 | 46 | 67 | 100 | 144 | |
| Deferred gain on retroactive reinsurance | 107 | 73 | — | — | — | |
| Liability for securities purchased | 6 | 0 | — | — | — | |
| Accrued expenses and other liabilities (includes $59,096 and $10,781 from related parties in 2024 and 2023, respectively) | 78 | 28 | 61 | 45 | 53 | |
| Senior notes - principal amount | 262 | 262 | 263 | 263 | 263 | |
| Less: unamortized issuance costs | 8 | 8 | 7 | 7 | 7 | |
| Senior notes, net | 255 | 255 | 256 | 255 | 255 | |
| Liabilities held for sale | 883,000 | 0 | — | — | — | |
| Total liabilities | 1,271 | 1,270 | 1,562 | 1,938 | 2,421 | |
| Commitments and Contingencies | — | — | — | — | — | |
| Common shares ($0.01 par value; shares issued 2024 - 150,298,798; 2023 - 149,732,355; shares outstanding 2024 - 99,039,253; 2023 - 100,472,120) | 2 | 1 | 1 | 923,000 | 898,000 | |
| Additional paid-in capital | 888 | 886 | 884 | 769 | 756 | |
| Accumulated other comprehensive loss | −33 | −31 | −41 | −12 | 24 | |
| Accumulated deficit | −688 | −487 | −443 | −498 | −616 | |
| Treasury shares, at cost (2024 - 51,259,545 shares; 2023 - 49,260,235 shares ) | −124 | −120 | −117 | −34 | — | |
| Total Maiden shareholders equity | 45 | 249 | 285 | 384 | 528 | |
| Total liabilities and equity | 1,316 | 1,519 | 1,847 | 2,323 | 2,948 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 | FY 2020 2020-12-31 |
|---|---|---|---|---|---|---|
| Non-cash expenses including depreciation, amortization and share-based compensation | −5 | −1 | −112,000 | 8 | 9 | |
| Change in allowance for expected credit losses | −296,000 | −1 | 0 | — | — | |
| Reinsurance balances receivable, net | 4 | −1 | 9 | −12 | 23 | |
| Reinsurance recoverable on unpaid losses | 12 | 14 | 11 | 594,000 | −7 | |
| Accrued investment income | 981,000 | −387,000 | 1 | 5 | 7 | |
| Deferred commission and other acquisition expenses | 9 | 7 | 12 | 15 | 26 | |
| Funds withheld receivable | 16 | 27 | 4 | 16 | 56 | |
| Other assets | 2 | 2 | −2 | −2 | −4 | |
| Reserve for loss and loss adjustment expenses | 76 | −4 | −155 | −378 | −582 | |
| Unearned premiums | −16 | −21 | −33 | −43 | −78 | |
| Accrued expenses and other liabilities | 50 | −33 | 18 | −7 | −15 | |
| Net cash used in operating activities | −67 | −60 | −196 | −394 | −542 | |
| Purchases of fixed maturities | −527 | −184 | −79 | −248 | −459 | |
| Purchases of other investments | −28 | −49 | −40 | −55 | −34 | |
| Purchases of equity method investments | −10 | −13 | −56 | −44 | −40 | |
| Purchases of equity securities | 0 | −3 | −17 | −21 | — | |
| Proceeds from sales of fixed maturities | 62 | 99 | 214 | 478 | 505 | |
| Proceeds from maturities, paydowns and calls of fixed maturities | 480 | 162 | 98 | 345 | 620 | |
| Proceeds from sale and redemption of other investments | 69 | 18 | 4 | 832,000 | 2 | |
| Proceeds from sale and redemption of equity method investments | 9 | 20 | 61 | 7 | 2 | |
| Proceeds from sale and redemption of equity securities | 23 | 8 | 0 | 441,000 | — | |
| Others, net | −328,000 | −101,000 | −88,000 | −25,000 | −608,000 | |
| Net cash provided by investing activities | 78 | 59 | 189 | 464 | 596 | |
| Repurchase of senior notes | 0 | −95,000 | 0 | — | — | |
| Repurchase of common shares | −4 | −3 | −1 | −2 | −1,000 | |
| Net cash used in financing activities | −4 | −3 | −11 | −139 | −30 | |
| Effect of exchange rate changes on foreign currency cash | −1 | 335,000 | −1 | −470,000 | 4 | |
| Net increase (decrease) in cash, restricted cash and cash equivalents | 5 | −4 | −19 | −70 | 29 | |
| Cash paid for interest, net of amounts capitalized | 19 | 19 | 19 | 19 | 19 | |
| Cash paid for income taxes | 189,000 | 147,000 | 1 | 109,000 | 106,000 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro